ContractElectromedical Technologies, Inc • July 7th, 2020 • Surgical & medical instruments & apparatus • Nevada
THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO ELECTROMEDICAL TECHNOLOGIES, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
Consulting AgreementConsulting Agreement • July 7th, 2020 • Electromedical Technologies, Inc • Surgical & medical instruments & apparatus • Arizona
This consulting agreement (the “Agreement”) is made and entered on this day 1st day of July, 2019 (the “Effective Date”) by and between PYP Enterprises (hereinafter referred to as the “Consultant”) and Electromedical Technologies, Inc. (hereinafter referred to as the “Client”).
Electromedical Technologies, Inc. Convertible NoteElectromedical Technologies, Inc • July 7th, 2020 • Surgical & medical instruments & apparatus • Nevada
FOR VALUE RECEIVED, Electromedical Technologies, Inc., a Delaware corporation with a par value of $0.001 per common share (“Par Value”) (the "Company"), hereby promises to pay to the order of Vista Capital Investments, LLC or registered assigns (the "Holder") the amount set out above as the Original Principal Amount (as reduced pursuant to the terms hereof pursuant to redemption, conversion or otherwise, the "Principal") when due, whether upon the Maturity Date (as defined below), acceleration, redemption or otherwise (in each case in accordance with the terms hereof) and to pay interest ("Interest") on any outstanding Principal at the applicable Interest Rate from the date set out above as the Issuance Date (the "Issuance Date") until the same becomes due and payable, upon the Maturity Date or acceleration, conversion, redemption or otherwise (in each case in accordance with the terms hereof).
ContractConsulting Agreement • July 7th, 2020 • Electromedical Technologies, Inc • Surgical & medical instruments & apparatus
Consulting Agreement This consulting agreement (the "Agreement") is made and entered on this day 11th day of February (the "Effective Date") by and between Robert L. Hymers III (hereinafter referred to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter referred to as the "Client"). 1. Services The Consultant will provide strategic business and business services to the Client, which may include: • Financial Consulting assistance with review of quarterly and annual filings with OTC Markets and/or the SEC. • Corporate Governance and Compliance • Communication, review and coordination of document transfers to auditors and attorneys. • Assistance with negotiation with contracts, financings, contracts and review and drafting of corresponding agreements, all of which must be pre-approved by the Client's legal counsel. • Communication with SEC attorney, auditors and outside accountants to complete resolutions and regulatory filings The scope of services will be subject to
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 7th, 2020 • Electromedical Technologies, Inc • Surgical & medical instruments & apparatus • Nevada
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 4, 2020, is entered into by and between ELECTROMEDICAL TECHNOLOGIES, INC., a Delaware corporation, (the “Company”), and VISTA CAPITAL INVESTMENTS, LLC (the “Buyer”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • July 7th, 2020 • Electromedical Technologies, Inc • Surgical & medical instruments & apparatus
This Stock Purchase Agreement is dated as of this 25" day of March, 2019 by and between Matthew Wolfson (the ASeller”) and Petar Gajic (the “Buyer’).
ContractSeries 1 Kiss Agreement • July 7th, 2020 • Electromedical Technologies, Inc • Surgical & medical instruments & apparatus
ADDENDUM TO SERIES 1 KISS AGREEMENT This Addendum to Series 1 Kiss Agreement ("Agreement") is entered into as of the 22nd day of March, 2019 by and between Electromedical Technologies, Inc., a Delaware corporation (the "Company"), and Blue Ridge Enterprises, LLC, a California Limited Liability Corporation ("BRE"). WHEREAS, on July 9, 2018 the Company and BRE entered into a Series 1 Kiss Agreement in the amount of $35,000; and WHEREAS, the funding for the Kiss Agreement was not fulfilled until November 1, 2018. NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, the parties hereby agree as follows: 1. The date of issuance for the Kiss Agreement is amended 2018 from July 9, 2018 to November 1. The contributions by Donald Steinberg, individually, to the Company in the amounts of(A) $10,000 on May 30, 2018; (B) $10,000 on June 18, 2018; and (C) $15,0
ContractAccredited Subscription Agreement • July 7th, 2020 • Electromedical Technologies, Inc • Surgical & medical instruments & apparatus
ACCREDITED SUBSCRIPTION AGREEMENT This Accredited Subscription Agreement ("Agreement”) is entered into as of the 31 day of October 2018 by and between Electromedical Technologies, Inc., a Delaware corporation (the "Company"), and the undersigned investor, Gene Taubman, (the "Investor"). If more than one person signs this Agreement as an investor, then all references to Investor in this Agreement include the co-investor(s), jointly and severally. 1. Subscription. Investor hereby irrevocably subscribes for 100,000 shares of the Company's common stock (the "Shares") at a price of$1.00 per share for a total purchase price of $100,000.00, subject to acceptance by the Company. 2. Approval and Acceptance. The effectiveness of this Agreement is subject to acceptance by the Company by signing below where indicated. If this Agreement is not approved and accepted, then the Company will notify Investor and return any funds Investor may have delivered to the Company promptly after non-acceptance. 3
